HK1139076A1 - Lyophilized preparation comprising influenza vaccine, and method for preparation thereof - Google Patents

Lyophilized preparation comprising influenza vaccine, and method for preparation thereof

Info

Publication number
HK1139076A1
HK1139076A1 HK10105830.1A HK10105830A HK1139076A1 HK 1139076 A1 HK1139076 A1 HK 1139076A1 HK 10105830 A HK10105830 A HK 10105830A HK 1139076 A1 HK1139076 A1 HK 1139076A1
Authority
HK
Hong Kong
Prior art keywords
influenza vaccine
preparation
freeze
iii
dried preparation
Prior art date
Application number
HK10105830.1A
Other languages
English (en)
Inventor
Chikamasa Yamashita
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1139076A1 publication Critical patent/HK1139076A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK10105830.1A 2007-03-09 2010-06-10 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof HK1139076A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007059724 2007-03-09
PCT/JP2008/054210 WO2008111532A1 (ja) 2007-03-09 2008-03-07 インフルエンザワクチン含有凍結乾燥製剤、及びその製造方法

Publications (1)

Publication Number Publication Date
HK1139076A1 true HK1139076A1 (en) 2010-09-10

Family

ID=39759470

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10105830.1A HK1139076A1 (en) 2007-03-09 2010-06-10 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof

Country Status (20)

Country Link
US (1) US8216588B2 (pt)
EP (1) EP2119451A4 (pt)
JP (1) JP5388842B2 (pt)
KR (1) KR20090128463A (pt)
CN (1) CN101631563B (pt)
AR (1) AR065640A1 (pt)
AU (1) AU2008225501B2 (pt)
BR (1) BRPI0808037A2 (pt)
CA (1) CA2680193C (pt)
HK (1) HK1139076A1 (pt)
IL (1) IL200588A0 (pt)
MX (1) MX2009009635A (pt)
MY (1) MY149924A (pt)
NZ (1) NZ579395A (pt)
RU (1) RU2484847C2 (pt)
SG (1) SG179406A1 (pt)
TW (1) TWI428140B (pt)
UA (1) UA97391C2 (pt)
WO (1) WO2008111532A1 (pt)
ZA (1) ZA200905952B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614460D0 (en) * 2006-07-20 2006-08-30 Novartis Ag Vaccines
CN108588035A (zh) * 2011-06-28 2018-09-28 白血球保健股份有限公司 病毒或细菌的新型稳定方法
WO2014117056A1 (en) * 2013-01-25 2014-07-31 Wintermute Biomedical, Llc Therapeutic compounds
GB201314248D0 (en) * 2013-08-08 2013-09-25 Glaxosmithkline Biolog Sa Saccharide vaccine formulation
CA2923010C (en) * 2013-09-03 2022-08-30 Georgia Tech Research Corporation Thermally stable vaccine formulations and microneedles
US10588957B2 (en) * 2013-10-25 2020-03-17 Leukocare Ag Method for the production of stabile vaccines
WO2017090767A1 (ja) * 2015-11-27 2017-06-01 日東電工株式会社 インフルエンザワクチン乾燥製剤、及び、インフルエンザワクチン乾燥製剤の製造方法
EP3381467A4 (en) 2015-11-27 2019-06-05 Nitto Denko Corporation PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING A PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION
TW201720426A (zh) 2015-11-27 2017-06-16 Nitto Denko Corp 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法
US11065220B2 (en) 2017-02-13 2021-07-20 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
CA3115050A1 (en) 2018-10-01 2020-04-09 Wintermute Biomedical, Inc. Therapeutic compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
JPH07121871B2 (ja) * 1986-10-09 1995-12-25 国立予防衛生研究所長 インフルエンザワクチン凍結乾燥製剤
JPH05229960A (ja) * 1990-10-30 1993-09-07 Dai Ichi Seiyaku Co Ltd 新規インフルエンザワクチン
JPH0813753B2 (ja) * 1992-05-22 1996-02-14 株式会社微生物化学研究所 牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ３型ウイルス感染症、牛ｒｓウイルス感染症および牛アデノ７型ウイルス感染症５種混合生ワクチン
CA2403962C (en) * 2000-03-31 2009-12-15 Kirin Beer Kabushiki Kaisha Powdery preparation for transmucosal administration comprising a medicine of high molecular weight and exhibiting an improved storage stability
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
JP2004054555A (ja) * 2002-07-19 2004-02-19 Yokogawa Electric Corp 表示装置
EP1597400B8 (en) * 2003-02-25 2013-10-09 MedImmune, LLC Methods of producing influenza vaccine compositions
CN101060859B (zh) * 2004-10-06 2011-11-09 米迪缪尼有限公司 冷藏温度稳定的流感疫苗组合物
RU2290205C1 (ru) * 2005-09-13 2006-12-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунологическим препаратам "МИКРОГЕН" Министерства здравоохранения Российской Федерации Способ получения живой вакцины для профилактики гриппа

Also Published As

Publication number Publication date
UA97391C2 (ru) 2012-02-10
ZA200905952B (en) 2010-11-24
RU2484847C2 (ru) 2013-06-20
MY149924A (en) 2013-10-31
TW200848074A (en) 2008-12-16
AU2008225501B2 (en) 2013-08-29
KR20090128463A (ko) 2009-12-15
JPWO2008111532A1 (ja) 2010-06-24
NZ579395A (en) 2012-05-25
BRPI0808037A2 (pt) 2014-06-17
EP2119451A4 (en) 2012-05-16
US8216588B2 (en) 2012-07-10
CN101631563A (zh) 2010-01-20
JP5388842B2 (ja) 2014-01-15
SG179406A1 (en) 2012-04-27
TWI428140B (zh) 2014-03-01
CN101631563B (zh) 2013-07-24
MX2009009635A (es) 2009-09-22
AU2008225501A2 (en) 2009-09-24
US20100104595A1 (en) 2010-04-29
AU2008225501A1 (en) 2008-09-18
WO2008111532A1 (ja) 2008-09-18
AR065640A1 (es) 2009-06-17
EP2119451A1 (en) 2009-11-18
RU2009137380A (ru) 2011-04-20
CA2680193A1 (en) 2008-09-18
IL200588A0 (en) 2010-05-17
CA2680193C (en) 2015-05-05

Similar Documents

Publication Publication Date Title
HK1139076A1 (en) Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
WO2010149743A3 (en) Vaccine
WO2007035455A3 (en) Stabilizers for freeze-dried vaccines
CA2746228C (en) Modified rsv f proteins and methods of their use
EP4349405A3 (en) Respiratory virus vaccines
WO2010146598A3 (en) Stable, dried rotavirus vaccine, compositions and process for preparation thereof
CA2817005A1 (en) Rabies glycoprotein virus-like particles (vlps)
JP2017533218A5 (pt)
WO2007048086A3 (en) Canine influenza virus and related compositions and methods of use
PL2443202T3 (pl) Wodna zawiesina aktywowanego powierzchniowo węglanu wapnia, otrzymane produkty i ich zastosowania
PE20100035A1 (es) Proteina de cereal hidrolizado parcialmente
NZ600891A (en) Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
MY184277A (en) Formulations of deoxyccholic acid and salts thereof
WO2009118754A3 (en) A process for preparing a stable lyophilized composition
MX2013005953A (es) Astringencia en soluciones de proteina de soya.
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
MX349837B (es) Composicion de transglutaminasa seca.
WO2011051916A3 (en) Stabilized protein formulations and use thereof
NZ613554A (en) Caprylate viral deactivation
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії
ATE415151T1 (de) Formulierung zur verzögerten freisetzung von valproinsäure und deren derivate
TH108771A (th) สารปรุงสำเร็จที่แห้งแบบเยือกแข็งที่มีวัคซีนไข้หวัดใหญ่ และวิธีสำหรับผลิตสารดังกล่าว
MX2015009141A (es) Formulaciones de albu-bche, preparacion y usos de las mismas.
TH108771B (th) สารปรุงสำเร็จที่แห้งแบบเยือกแข็งที่มีวัคซีนไข้หวัดใหญ่ และวิธีสำหรับผลิตสารดังกล่าว
WO2010095978A3 (ru) Способ получения препарата проинсулина для перорального применения

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170307